Redox proteomics analysis of brains from subjects with amnestic mild cognitive impairment compared to brains from subjects with preclinical Alzheimer’s disease: Insights into memory loss in MCI

Mild cognitive impairment as a diagnostic entity

Petersen, R. C. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01388.x · Cited by 7,864 · see citing works

Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory

Shankar, G. M., Li, S., Mehta, T. H., Garcia-Munoz, A., Shepardson, N. E., Smith, I., Brett, F. M., Farrell, M. A., Rowan, M. J., Lemere, C. A., et al. (2008) · Nature Medicine · doi:10.1038/nm1782 · Cited by 3,685 · see citing works

Amyloid β-peptide is produced by cultured cells during normal metabolism

Haass, C., Schlossmacher, M. G., Hung, A. Y., Vigo-Pelfrey, C., Mellon, A., Ostaszewski, B. L., Lieberburg, I., Koo, E. H., Schenk, D., Teplow, D. B., et al. (1992) · Nature · doi:10.1038/359322a0 · Cited by 1,921 · see citing works

Profound Loss of Layer II Entorhinal Cortex Neurons Occurs in Very Mild Alzheimer’s Disease

Gómez-Isla, T., Price, J. L., McKeel Jr., D. W., Morris, J. C., Growdon, J. H., & Hyman, B. T. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-14-04491.1996 · Cited by 1,796 · see citing works

Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids

Seubert, P., Vigo-Pelfrey, C., Esch, F., Lee, M., Dovey, H., Davis, D., Sinha, S., Schiossmacher, M., Whaley, J., Swindlehurst, C., et al. (1992) · Nature · doi:10.1038/359325a0 · Cited by 1,731 · see citing works

Natural Oligomers of the Alzheimer Amyloid-β Protein Induce Reversible Synapse Loss by Modulating an NMDA-Type Glutamate Receptor-Dependent Signaling Pathway

Shankar, G. M., Bloodgood, B. L., Townsend, M., Walsh, D. M., Selkoe, D. J., & Sabatini, B. L. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4970-06.2007 · Cited by 1,592 · see citing works

Production of the Alzheimer Amyloid β Protein by Normal Proteolytic Processing

Shoji, M., Golde, T. E., Ghiso, J., Cheung, T. T., Estus, S., Shaffer, L. M., Cai, X.-D., McKay, D. M., Tintner, R., Frangione, B., et al. (1992) · Science · doi:10.1126/science.1439760 · Cited by 1,447 · see citing works

Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease.

Smith, C. D., Carney, J. M., Starke-Reed, P. E., Oliver, C. N., Stadtman, E. R., Floyd, R. A., & Markesbery, W. R. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.23.10540 · Cited by 1,296 · see citing works

Soluble Oligomers of Amyloid β Protein Facilitate Hippocampal Long-Term Depression by Disrupting Neuronal Glutamate Uptake

Li, S., Hong, S., Shepardson, N. E., Walsh, D. M., Shankar, G. M., & Selkoe, D. (2009) · Neuron · doi:10.1016/j.neuron.2009.05.012 · Cited by 972 · see citing works

Oxidative damage in Alzheimer's

Smith, M. A., Perry, G. L., Richey, P. L., Sayrec, L. M., Anderson, V. E., Beal, M. F., & Kowall, N. W. (1996) · Nature · doi:10.1038/382120b0 · Cited by 897 · see citing works

In vitro aging of ß-amyloid protein causes peptide aggregation and neurotoxicity

Pike, C. J., Walencewicz, A. J., Glabe, C. G., & Cotman, C. W. (1991) · Brain Research · doi:10.1016/0006-8993(91)91553-d · Cited by 829 · see citing works

Neuropathology of nondemented aging: presumptive evidence for preclinical Alzheimer disease

Price, J. L., McKeel, D. W., Buckles, V. D., Roe, C. M., Xiong, C., Grundman, M., Hansen, L. A., Petersen, R. C., Parisi, J. E., Dickson, D. W., et al. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.04.002 · Cited by 661 · see citing works

Neuron Number in the Entorhinal Cortex and CA1 in Preclinical Alzheimer Disease

Price, J. L., Ko, A. I., Wade, M. J., Tsou, S. K., McKeel, D. W., & Morris, J. C. (2001) · Archives of Neurology · doi:10.1001/archneur.58.9.1395 · Cited by 596 · see citing works

Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part II: dihydropyrimidinase‐related protein 2, α‐enolase and heat shock cognate 71

Castegna, A., Aksenov, M. Y., Thongboonkerd, V., Klein, J. B., Pierce, W. M. J., Booze, R. M., Markesbery, W. R., & Butterfield, D. A. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01103.x · Cited by 581 · see citing works

Proteomic identification of oxidatively modified proteins in Alzheimer’s disease brain. Part I: Creatine kinase BB, glutamine synthase, and ubiquitin carboxy-terminal hydrolase L-1

Castegna, A., Aksenov, M., Aksenova, M., Thongboonkerd, V., Klein, J. B., Pierce, W. M., Booze, R., Markesbery, W. R., & Butterfield, D. A. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)00914-0 · Cited by 581 · see citing works

Oxidative Modifications and Down-regulation of Ubiquitin Carboxyl-terminal Hydrolase L1 Associated with Idiopathic Parkinson's and Alzheimer's Diseases

Choi, J., Levey, A. I., Weintraub, S. T., Rees, H. D., Gearing, M., Chin, L.-S., & Li, L. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m314124200 · Cited by 568 · see citing works

α-Enolase, a Novel Strong Plasmin(ogen) Binding Protein on the Surface of Pathogenic Streptococci

Pancholi, V., & Fischetti, V. A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.23.14503 · Cited by 556 · see citing works

Aging renders the brain vulnerable to amyloid β-protein neurotoxicity

Guela, C., Wu, C.-K., Saroff, D., Lorenzo, A., Yuan, M., & Yankner, B. A. (1998) · Nature Medicine · doi:10.1038/nm0798-827 · Cited by 520 · see citing works

Protein oxidation in the brain in Alzheimer's disease

Aksenov, M. Y., Aksenova, M. V., Butterfield, D. A., Geddes, J. W., & Markesbery, W. R. (2001) · Neuroscience · doi:10.1016/s0306-4522(00)00580-7 · Cited by 503 · see citing works

The use of PET in Alzheimer disease

Nordberg, A. K., Rinne, J. O., Kadir, A., & Långström, B. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2009.217 · Cited by 451 · see citing works

Redox proteomics identification of oxidatively modified hippocampal proteins in mild cognitive impairment: Insights into the development of Alzheimer's disease

Butterfield, D. A., Poon, H. F., St. Clair, D., Keller, J. N., Pierce, W. M., Klein, J. B., & Markesbery, W. R. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.11.002 · Cited by 377 · see citing works

Redox proteomics identification of oxidized proteins in Alzheimer's disease hippocampus and cerebellum: An approach to understand pathological and biochemical alterations in AD

Rukhsana Sultana, A., Debra Boyd-kimball, A., Poon, H. F., Cai, J., Pierce, W. M. J., Klein, J. B., Merchant, M. L., Markesbery, W. R., & Butterfield, D. A. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.09.021 · Cited by 334 · see citing works

Hippocampal neurons in pre-clinical Alzheimer's disease.

West, M. J., Kawas, C. H., Stewart, W. F., Rudow, G. L., & Troncoso, J. C. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.12.005 · Cited by 317 · see citing works

Lipid peroxidation is an early event in the brain in amnestic mild cognitive impairment

Markesbery, W. R., Kryscio, R. J., Lovell, M. A., & Morrow, J. D. (2005) · Annals of Neurology · doi:10.1002/ana.20629 · Cited by 272 · see citing works

Structural Analysis of α-Enolase

Subramanian, A. K., & Miller, D. M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.8.5958 · Cited by 265 · see citing works

Redox proteomic identification of 4-Hydroxy-2-nonenal-modified brain proteins in amnestic mild cognitive impairment: Insight into the role of lipid peroxidation in the progression and pathogenesis of Alzheimer's disease

Reed, T., Perluigi, M., Sultana, R., Pierce, W. M., Klein, J. B., Turner, D. M., Coccia, R., Markesbery, W. R., & Butterfield, D. A. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2007.12.007 · Cited by 257 · see citing works

Oxidative modification and down-regulation of Pin1 in Alzheimer's disease hippocampus: A redox proteomics analysis

Rukhsana Sultana, A., Debra Boyd-kimball, A., Poon, H. F., Cai, J., Pierce, W. M. J., Klein, J. B., Markesbery, W. R., Zhou, X. Z., Lu, K. P., & Butterfield, D. A. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.05.005 · Cited by 255 · see citing works

Elevated protein-bound levels of the lipid peroxidation product, 4-hydroxy-2-nonenal, in brain from persons with mild cognitive impairment

Butterfield, D. A., Reed, T., Perluigi, M., De Marco, C., Coccia, R., Cini, C., & Sultana, R. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2005.12.017 · Cited by 246 · see citing works

Oxidative damage in mild cognitive impairment and early Alzheimer's disease

Lovell, M. A., & Markesbery, W. R. (2007) · Journal of Neuroscience Research · doi:10.1002/jnr.21346 · Cited by 245 · see citing works

Cytochemical Demonstration of Oxidative Damage in Alzheimer Disease by Immunochemical Enhancement of the Carbonyl Reaction with 2,4-Dinitrophenylhydrazine

Smith, M. A., Sayre, L. M., Anderson, V. E., Harris, P. L. R., Beal, M. F., Kowall, N. W., & Perry, G. L. (1998) · Journal of Histochemistry & Cytochemistry · doi:10.1177/002215549804600605 · Cited by 222 · see citing works

Oxidatively modified proteins in Alzheimer’s disease (AD), mild cognitive impairment and animal models of AD: role of Abeta in pathogenesis

Sultana, R., Perluigi, M., & Butterfield, D. A. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0517-0 · Cited by 215 · see citing works

Untitled work

Iacono (2009) · doi:10.1212/wnl.0b013e3181b01077 · Cited by 203 · see citing works

Proteomic identification of brain proteins in the canine model of human aging following a long-term treatment with antioxidants and a program of behavioral enrichment: Relevance to Alzheimer's disease

Opii, W. O., Joshi, G., Head, E., Milgram, N. W., Muggenburg, B. A., Klein, J. B., Pierce, W. M., Cotman, C. W., & Butterfield, D. A. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.09.012 · Cited by 202 · see citing works

Increased levels of 4-hydroxynonenal and acrolein in the brain in preclinical Alzheimer disease

Bradley, M. A., Markesbery, W. R., & Lovell, M. A. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.02.016 · Cited by 193 · see citing works

Proteomic identification of HNE-bound proteins in early Alzheimer disease: Insights into the role of lipid peroxidation in the progression of AD

Reed, T. T., Pierce, W. M., Markesbery, W. R., & Butterfield, D. A. (2009) · Brain Research · doi:10.1016/j.brainres.2009.04.009 · Cited by 190 · see citing works

Blood-brain barrier disturbance in patients with Alzheimer's disease is related to vascular factors

Blennow, K., Wallin, A., Fredman, P., Karlsson, I., Gottfries, C. G., & Svennerholm, L. T. (2009) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1990.tb01563.x · Cited by 185 · see citing works

An immunochemical study of the pyruvate dehydrogenase deficit in Alzheimer's disease brain

Sheu, K. R., Kim, Y., Blass, J. P., & Weksler, M. E. (1985) · Annals of Neurology · doi:10.1002/ana.410170505 · Cited by 180 · see citing works

Non-neuronal Enolase Is an Endothelial Hypoxic Stress Protein

Aaronson, R. M., Graven, K. K., Tucci, M., McDonald, R. J., & Farber, H. W. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.46.27752 · Cited by 155 · see citing works

Absence of cognitive impairment or decline in preclinical Alzheimer’s disease

Goldman, W. P., Price, J. L., Storandt, M., Grant, E., McKeel, D. W., Rubin, E. H., & Morris, J. C. (2001) · Neurology · doi:10.1212/wnl.56.3.361 · Cited by 143 · see citing works

Neuropathologic Studies of the Baltimore Longitudinal Study of Aging (BLSA)

O'Brien, R. J., Resnick, S. M., Zonderman, A. B., Ferrucci, L., Crain, B. J., Pletnikova, O., Rudow, G., Iacono, D., Riudavets, M. A., Driscoll, I., et al. (2009) · Journal of Alzheimer's Disease · doi:10.3233/jad-2009-1179 · Cited by 137 · see citing works

Brain protein and α‐ketoglutarate dehydrogenase complex activity in alzheimer‐s disease

Mastrogiacomo, F., LINDSAY, J. G., Bettendorff, L., Rice, J., & Kish, S. J. (1996) · Annals of Neurology · doi:10.1002/ana.410390508 · Cited by 132 · see citing works

Free radical damage, iron, and Alzheimer's disease

Smith, M. A., & Perry, G. L. (1995) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(95)00213-l · Cited by 130 · see citing works

Redox proteomic analysis of carbonylated brain proteins in mild cognitive impairment and early Alzheimer’s disease

Sultana, R., Perluigi, M., Newman, S. F., Pierce, W. M., Cini, C., Coccia, R., & Butterfield, D. A. (2010) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2810 · Cited by 125 · see citing works

Plasminogen Binds Specifically to α‐Enolase on Rat Neuronal Plasma Membrane

Nakajima, K., Hamanoue, M., Takemoto, N., Hattori, T., Kato, K., & Kohsaka, S. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.63062048.x · Cited by 122 · see citing works

Human Diseases with Defects in Oxidative Phosphorylation. 2. F1F0 ATP-Synthase Defects in Alzheimer Disease Revealed by Blue Native Polyacrylamide Gel Electrophoresis

Schägger, H., & Ohm, T. G. (1995) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1995.tb20219.x · Cited by 117 · see citing works

Cloning and characterization of a human c-myc promoter-binding protein.

Ray, R. B., & Miller, D. M. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.4.2154 · Cited by 116 · see citing works

Protein Levels and Activity of Some Antioxidant Enzymes in Hippocampus of Subjects with Amnestic Mild Cognitive Impairment

Rukhsana Sultana, A., Piroddi, M., Galli, F., & Butterfield, D. A. (2008) · Neurochemical Research · doi:10.1007/s11064-008-9593-0 · Cited by 115 · see citing works

Alterations of Zinc Transporter Proteins ZnT‐1, ZnT‐4 and ZnT‐6 in Preclinical Alzheimer's Disease Brain

Ganna Lyubartseva, A., Smith, J. L., Markesbery, W. R., & Lovell, M. A. (2009) · Brain Pathology · doi:10.1111/j.1750-3639.2009.00283.x · Cited by 103 · see citing works

Fluoride Exposure Attenuates Expression of Streptococcus pyogenes Virulence Factors

Thongboonkerd, V., Luengpailin, J., Cao, J., Pierce, W. M. J., Cai, J., Klein, J. B., & Doyle, R. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200746200 · Cited by 102 · see citing works

JNK1 Mediates Degradation HIF-1α by a VHL-Independent Mechanism that Involves the Chaperones Hsp90/Hsp70

Zhang, D., Li, J., Costa, M., Gao, J., & Huang, C. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-0448 · Cited by 99 · see citing works

Neuronal Survival Factor from Bovine Brain Is Identical to Neuron‐Specific Enolase

Takei, N., Kondo, J., Nagaike, K., Ohsawa, K., Kato, K., & Kohsaka, S. (1991) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1991.tb08277.x · Cited by 98 · see citing works

Decreased expression of nuclear and mitochondrial DNA-encoded genes of oxidative phosphorylation in association neocortex in Alzheimer disease.

Chandrasekaran, K., Hatanpaa, K., Rapoport, S., & Brady, D. (1997) · Brain Research. Molecular Brain Research · doi:10.1016/s0169-328x(96)00191-x · Cited by 95 · see citing works

Neurotrophic and neuroprotective effects of neuron-specific enolase on cultured neurons from embryonic rat brain

Hattori, T., Takei, N., Mizuno, Y., Kato, K., & Kohsaka, S. (1995) · Neuroscience Research · doi:10.1016/0168-0102(94)00849-b · Cited by 94 · see citing works

Decreased Expression of Hippocampal Cholinergic Neurostimulating Peptide Precursor Protein mRNA in the Hippocampus in Alzheimer Disease

Maki, M., Matsukawa, N., Yuasa, H., Otsuka, Y., Yamamoto, T., Akatsu, H., Okamoto, T., Ueda, R., & Ojika, K. (2002) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/61.2.176 · Cited by 83 · see citing works

Preclinical Alzheimer disease: Brain oxidative stress, Aβ peptide and proteomics

Aluise, C. D., Sowell, R. A., Beckett, T. L., Murphy, M. P., Cai, J., Pierce, W. M. J., Markesbery, W. R., & Butterfield, D. A. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.04.011 · Cited by 83 · see citing works

Decreased phosphatidylethanolamine binding protein expression correlates with Aβ accumulation in the Tg2576 mouse model of Alzheimer's disease

George, A. J., Holsinger, R. M. D., McLean, C., Tan, S., Scott, H. S., Cardamone, T., Cappai, R., Masters, C. L., & Li, Q. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.03.014 · Cited by 69 · see citing works

Quantitative solubilization and analysis of insoluble paired helical filaments from Alzheimer disease.

Smith, M. A., Siedlak, S., Richey, P., Nagaraj, R., Elhammer, Å., & Perry, G. (1996) · Brain Research · doi:10.1016/0006-8993(95)01473-x · Cited by 58 · see citing works

Decreased expression of hippocampal cholinergic neurostimulating peptide precursor protein mRNA in the hippocampus in Alzheimer's disease

牧, 美. (2002) · Medical Entomology and Zoology · Cited by 58 · see citing works

Synthetic Peptide Corresponding to 30 Amino Acids of the C-Terminal of Neuron-Specific Enolase Promotes Survival of Neocortical Neurons in Culture

Hattori, T., Ohsawa, K., Mizuno, Y., Kato, K., & Kohsaka, S. (1994) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1994.1888 · Cited by 36 · see citing works

Plasmin Deficiency in Alzheimer’s Disease Brains: Causal or Casual?

Dotti, C. G., Galván, C. A., & Ledesma, M. D. (2004) · Neurodegenerative Diseases · doi:10.1159/000080987 · Cited by 24 · see citing works

Oxidative stress and the amyloid beta peptide in Alzheimer’s disease

Cheignon, C., Tomas, M., Bonnefont-Rousselot, D., Faller, P., Hureau, C., & Collin, F. (2018) · Redox Biology · doi:10.1016/j.redox.2017.10.014 · Cited by 2,185 · see citing works

Free radicals and antioxidants: updating a personal view

Halliwell, B. B. (2012) · Nutrition Reviews · doi:10.1111/j.1753-4887.2012.00476.x · Cited by 918 · see citing works

Amyloid <i>β</i> -Peptide (1–42)-Induced Oxidative Stress in Alzheimer Disease: Importance in Disease Pathogenesis and Progression

Butterfield, D. A., Swomley, A. M., & Sultana, R. (2013) · Antioxidants &amp; Redox Signaling · doi:10.1089/ars.2012.5027 · Cited by 526 · see citing works

Inflammation and Oxidative Stress: The Molecular Connectivity between Insulin Resistance, Obesity, and Alzheimer’s Disease

Verdile, G., Keane, K. N., Cruzat, V. F., Medic, S., Sabale, M., Rowles, J., Wijesekara, N., Martins, R. N., Fraser, P. E., & Newsholme, P. (2015) · Mediators of Inflammation · doi:10.1155/2015/105828 · Cited by 501 · see citing works

Lipid peroxidation triggers neurodegeneration: A redox proteomics view into the Alzheimer disease brain

Sultana, R., Perluigi, M., & Butterfield, D. A. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.09.027 · Cited by 478 · see citing works

Neuropathology of sporadic Parkinson's disease: Evaluation and changes of concepts

Jellinger, K. A. (2011) · Movement Disorders · doi:10.1002/mds.23795 · Cited by 448 · see citing works

Elevated risk of type 2 diabetes for development of Alzheimer disease: A key role for oxidative stress in brain

Butterfield, D. A., Di Domenico, F., & Barone, E. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.06.010 · Cited by 402 · see citing works

Lipid peroxidation and neurodegenerative disease

Reed, T. T. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.06.027 · Cited by 380 · see citing works

Alteration of mTOR signaling occurs early in the progression of Alzheimer disease (AD): analysis of brain from subjects with pre‐clinical AD, amnestic mild cognitive impairment and late‐stage AD

Tramutola, A., Triplett, J. C., Di Domenico, F., Niedowicz, D. M., Murphy, M. P., Coccia, R., Perluigi, M., & Butterfield, D. A. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13037 · Cited by 347 · see citing works

The antioxidant paradox: less paradoxical now?

Halliwell, B. (2013) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2012.04272.x · Cited by 318 · see citing works

Oxidative stress, protein modification and Alzheimer disease

Tramutola, A., Lanzillotta, C., Perluigi, M., & Butterfield, D. A. (2017) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2016.06.005 · Cited by 303 · see citing works

Oxidative damage in neurodegeneration: roles in the pathogenesis and progression of Alzheimer disease

Marzia Perluigi, A., Domenico, F. D., & Butterfield, D. A. (2023) · Physiological Reviews · doi:10.1152/physrev.00030.2022 · Cited by 306 · see citing works

The role of type 2 diabetes in neurodegeneration

Verdile, G., Fuller, S. J., & Martins, R. N. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.04.008 · Cited by 276 · see citing works

Redox Proteomics: Chemical Principles, Methodological Approaches and Biological/Biomedical Promises

Bachi, A., Dalle‐Donne, I., & Scaloni, A. (2012) · Chemical Reviews · doi:10.1021/cr300073p · Cited by 262 · see citing works

4-Hydroxy-2-nonenal, a reactive product of lipid peroxidation, and neurodegenerative diseases: a toxic combination illuminated by redox proteomics studies

Perluigi, M., Coccia, R., & Butterfield, D. A. (2012) · Antioxidants &amp; Redox Signaling · doi:10.1089/ars.2011.4406 · Cited by 229 · see citing works

Mitochondria and Brain Disease: A Comprehensive Review of Pathological Mechanisms and Therapeutic Opportunities

Clemente‐Suárez, V. J., Redondo-Flórez, L., Beltrán-Velasco, A. I., Ramos‐Campo, D. J., Belinchón-deMiguel, P., Martínez‐Guardado, I., Dalamitros, A. A., Sepulveda, R. A. Y., Martín-Rodríguez, A., & Tornero-Aguilera, J. F. (2023) · Biomedicines · doi:10.3390/biomedicines11092488 · Cited by 241 · see citing works

Oxidative Damage to RNA in Aging and Neurodegenerative Disorders

Nunomura, A., Moreira, P. I., Castellani, R. J., Lee, H., Zhu, X., Smith, M. A., & Perry, G. L. (2012) · Neurotoxicity Research · doi:10.1007/s12640-012-9331-x · Cited by 183 · see citing works

Oxidative stress in Alzheimer disease and mild cognitive impairment: evidence from human data provided by redox proteomics

Swomley, A. M., & Butterfield, D. A. (2015) · Archives of Toxicology · doi:10.1007/s00204-015-1556-z · Cited by 171 · see citing works

Redox Proteomics in Selected Neurodegenerative Disorders: From Its Infancy to Future Applications

Butterfield, D. A., Marzia Perluigi, A., Reed, T. T., Muharib, T., Hughes, C. P., Robinson, R. A. S., & Rukhsana Sultana, A. (2011) · Antioxidants and Redox Signaling · doi:10.1089/ars.2011.4109 · Cited by 167 · see citing works

Doxorubicin-induced elevated oxidative stress and neurochemical alterations in brain and cognitive decline: protection by MESNA and insights into mechanisms of chemotherapy-induced cognitive impairment (“chemobrain”)

Keeney, J. T. R., Ren, X., Warrier, G., Noel, T. J., Powell, D. K., Brelsfoard, J., Rukhsana Sultana, A., Saatman, K. E., Clair, D. K. S., & Butterfield, D. A. (2018) · Oncotarget · doi:10.18632/oncotarget.25718 · Cited by 159 · see citing works

The Earliest Stage of Cognitive Impairment in Transition From Normal Aging to Alzheimer Disease Is Marked by Prominent RNA Oxidation in Vulnerable Neurons

Nunomura, A., Tamaoki, T., Motohashi, N., Nakamura, M., McKeel, D. W., Tabaton, M., Lee, H., Smith, M. A., Perry, G. L., & Zhu, X. (2012) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e318248e614 · Cited by 131 · see citing works

Origin and pathophysiology of protein carbonylation, nitration and chlorination in age-related brain diseases and aging

Gonos, E. S., Καπετάνου, Μ., Sereikaitė, J., Bartosz, G., Naparło, K., Grzesik, M., & Sadowska‐Bartosz, I. (2018) · Aging · doi:10.18632/aging.101450 · Cited by 133 · see citing works

The 2013 SFRBM Discovery Award: Selected discoveries from the Butterfield laboratory of oxidative stress and its sequela in brain in cognitive disorders exemplified by Alzheimer disease and chemotherapy induced cognitive impairment

Butterfield, D. A. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.06.006 · Cited by 126 · see citing works

Epigenomics of Alzheimer's disease

Bennett, D. A., Yu, L., Yang, J., Srivastava, G. P., Aubin, C., & Jager, P. L. D. (2014) · Translational research · doi:10.1016/j.trsl.2014.05.006 · Cited by 124 · see citing works

mTOR in Alzheimer disease and its earlier stages: Links to oxidative damage in the progression of this dementing disorder

Marzia Perluigi, A., Domenico, F. D., Barone, E., & Butterfield, D. A. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.04.025 · Cited by 121 · see citing works

Neurodegeneration and Alzheimer's disease (AD). What Can Proteomics Tell Us About the Alzheimer's Brain?

Moya‐Alvarado, G., Gershoni‐Emek, N., Perlson, E., & Bronfman, F. C. (2016) · Molecular & Cellular Proteomics · doi:10.1074/mcp.r115.053330 · Cited by 119 · see citing works

The Triangle of Death in Alzheimer's Disease Brain: The Aberrant Cross-Talk Among Energy Metabolism, Mammalian Target of Rapamycin Signaling, and Protein Homeostasis Revealed by Redox Proteomics

Di Domenico, F., Barone, E., Perluigi, M., & Butterfield, D. A. (2017) · Antioxidants &amp; Redox Signaling · doi:10.1089/ars.2016.6759 · Cited by 114 · see citing works

Mass spectrometry and redox proteomics: Applications in disease

Butterfield, D. A., Gu, L., Domenico, F. D., & Robinson, R. A. S. (2013) · Mass Spectrometry Reviews · doi:10.1002/mas.21374 · Cited by 113 · see citing works

Redox proteomics analysis to decipher the neurobiology of Alzheimer-like neurodegeneration: overlaps in Down's syndrome and Alzheimer's disease brain

Butterfield, D. A., Domenico, F. D., Swomley, A. M., Head, E., & Marzia Perluigi, A. (2014) · Biochemical Journal · doi:10.1042/bj20140772 · Cited by 111 · see citing works

Nrf2/ARE Pathway Modulation by Dietary Energy Regulation in Neurological Disorders

Vasconcelos, A. R., dos Santos, N. B., Scavone, C., & Munhoz, C. D. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00033 · Cited by 112 · see citing works

Redox proteomics and amyloid β-peptide: Insights into Alzheimer disease

Butterfield, D. A., & Boyd‐Kimball, D. (2019) · Journal of Neurochemistry · doi:10.1111/jnc.14589 · Cited by 105 · see citing works

The diabetic brain and cognition

Riederer, P., Korczyn, A. D., Ali, S. S., Bajenaru, O. A., Choi, M. S., Chopp, M., Dobrota, V. Đ., Grünblatt, E., Jellinger, K. A., Kamal, M. A., et al. (2017) · Journal of Neural Transmission · doi:10.1007/s00702-017-1763-2 · Cited by 96 · see citing works

Mitochondrial Oxidative and Nitrosative Stress and Alzheimer Disease

Butterfield, D. A., & Boyd-Kimball, D. (2020) · Antioxidants · doi:10.3390/antiox9090818 · Cited by 85 · see citing works

Mitochondrial Abnormalities in Alzheimer’s Disease

Silva, D. F., Selfridge, J. E., Lu, J., E, L., Cardoso, S. M., & Swerdlow, R. H. (2012) · Advances in Pharmacology · doi:10.1016/b978-0-12-394816-8.00003-9 · Cited by 86 · see citing works

Mitochondrial Dysfunction

Leuner, K., Stockburger, C., Denzer, I., Eckert, G. P., & Müller, W. E. (2014) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-394625-6.00007-6 · Cited by 84 · see citing works

Oxidative Modification of Brain Proteins in Alzheimer's Disease: Perspective on Future Studies Based on Results of Redox Proteomics Studies

Rukhsana Sultana, A., & Butterfield, D. A. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-129018 · Cited by 83 · see citing works

Redox proteomics identification of specifically carbonylated proteins in the hippocampi of triple transgenic Alzheimer’s disease mice at its earliest pathological stage

Shen, L., Chen, C., Yang, A., Chen, Y., Liu, Q., & Ni, J. (2015) · Journal of Proteomics · doi:10.1016/j.jprot.2015.04.005 · Cited by 73 · see citing works

Targeting Mitochondria in Alzheimer Disease: Rationale and Perspectives

Lanzillotta, C., Domenico, F. D., Marzia Perluigi, A., & Butterfield, D. A. (2019) · CNS Drugs · doi:10.1007/s40263-019-00658-8 · Cited by 72 · see citing works

Exercise-Induced Benefits for Alzheimer’s Disease by Stimulating Mitophagy and Improving Mitochondrial Function

Liang, J., Wang, C., Zhang, H., Huang, J., Xie, J., & Chen, N. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.755665 · Cited by 66 · see citing works

Redox imbalance and morphological changes in skin fibroblasts in typical Rett syndrome

Signorini, C., Leoncini, S., De Felice, C., Pecorelli, A., Meloni, I., Ariani, F., Mari, F., Amabile, S., Paccagnini, E., Gentile, M., et al. (2014) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2014/195935 · Cited by 61 · see citing works

mTOR signaling as a molecular target for the alleviation of Alzheimer's disease pathogenesis

Rapaka, D., Bitra, V. R., Challa, S. R., & Adiukwu, P. C. (2022) · Neurochemistry International · doi:10.1016/j.neuint.2022.105311 · Cited by 65 · see citing works

α-Lipoic Acid, an Organosulfur Biomolecule a Novel Therapeutic Agent for Neurodegenerative Disorders: An Mechanistic Perspective

Khan, H., Singh, T. G., Singh, R., & Abdel‐Daim, M. M. (2022) · Neurochemical Research · doi:10.1007/s11064-022-03598-w · Cited by 62 · see citing works

Redox proteomics and the dynamic molecular landscape of the aging brain

Marzia Perluigi, A., Swomley, A. M., & Butterfield, D. A. (2013) · Ageing Research Reviews · doi:10.1016/j.arr.2013.12.005 · Cited by 59 · see citing works

Cell Cycle Proteins in Brain in Mild Cognitive Impairment: Insights into Progression to Alzheimer Disease

Keeney, J. T. R., Swomley, A. M., Harris, J. L., Fiorini, A., Mitov, M. I., Marzia Perluigi, A., Rukhsana Sultana, A., & Butterfield, D. A. (2011) · Neurotoxicity Research · doi:10.1007/s12640-011-9287-2 · Cited by 56 · see citing works

Loss of biliverdin reductase-A favors Tau hyper-phosphorylation in Alzheimer's disease

Sharma, N. K., Tramutola, A., Lanzillotta, C., Arena, A., Blarzino, C., Cassano, T., Butterfield, D. A., Domenico, F. D., Marzia Perluigi, A., & Barone, E. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.02.003 · Cited by 57 · see citing works

Perspectives on Oxidative Stress in Alzheimer’s Disease and Predictions of Future Research Emphases

Butterfield, D. A. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-179912 · Cited by 57 · see citing works

Isoprostanes and 4-Hydroxy-2-nonenal: Markers or Mediators of Disease? Focus on Rett Syndrome as a Model of Autism Spectrum Disorder

Signorini, C., Felice, C. D., Durand, T., Oger, C., Galano, J., Leoncini, S., Pecorelli, A., Valacchi, G., Ciccoli, L., & Hayek, J. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/343824 · Cited by 53 · see citing works

Redox Homeostasis and Prospects for Therapeutic Targeting in Neurodegenerative Disorders

Akanji, M. A., Rotimi, D. E., Elebiyo, T. C., Awakan, O. J., & Adeyemı, O. S. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/9971885 · Cited by 52 · see citing works

Redox Proteomics Analyses of the Influence of Co-Expression of Wild-Type or Mutated LRRK2 and Tau on C. elegans Protein Expression and Oxidative Modification: Relevance to Parkinson Disease

Domenico, F. D., Rukhsana Sultana, A., Ferree, A. W., Smith, K., Barone, E., Marzia Perluigi, A., Coccia, R., Pierce, W. M. J., Cai, J., Mancuso, C., et al. (2012) · Antioxidants and Redox Signaling · doi:10.1089/ars.2011.4312 · Cited by 51 · see citing works

Delineation of Neuroprotective Effects and Possible Benefits of AntioxidantsTherapy for the Treatment of Alzheimer's Diseases by Targeting Mitochondrial-Derived Reactive Oxygen Species: Bench to Bedside

Walia, V., Kaushik, D., Mittal, V., Kumar, K., Verma, R., Parashar, J., Akter, R., Rahman, M. H., Bhatia, S., Al-Harrasi, A., et al. (2022) · Molecular Neurobiology · doi:10.1007/s12035-021-02617-1 · Cited by 47 · see citing works

Early Molecular Changes in Alzheimer Disease: Can We Catch the Disease in its Presymptomatic Phase?

Wirz, K. T. S., Keitel, S., Swaab, D. F., Verhaagen, J., & Bossers, K. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-130920 · Cited by 47 · see citing works

Early intervention attenuates synaptic plasticity impairment and neuroinflammation in 5xFAD mice

Li, K., Wang, X., Jiang, Y., Zhang, X., Liu, Z., Yin, T., & Yang, Z. R. (2021) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2021.02.007 · Cited by 43 · see citing works

Disrupted brain functional connectivity as early signature in cognitively healthy individuals with pathological CSF amyloid/tau

Al‐Ezzi, A. A. A., Arechavala, R. J., Butler, R., Nolty, A., Kang, J. J. H., Shinsuke Shimojo, A., Wu, D.-A. J., Fonteh, A. N., Kleinman, M. T., Kloner, R. A., et al. (2024) · Communications Biology · doi:10.1038/s42003-024-06673-w · Cited by 42 · see citing works

Postsynaptic Proteome of Non-Demented Individuals with Alzheimer’s Disease Neuropathology

Zolochevska, O., Bjorklund, N., Woltjer, R., Wiktorowicz, J. E., & Taglialatela, G. (2018) · Journal of Alzheimer’s Disease · doi:10.3233/jad-180179 · Cited by 42 · see citing works

Protein Oxidation in Aging and Alzheimer’s Disease Brain

Rukhsana Sultana, A., & Butterfield, D. A. (2024) · Antioxidants · doi:10.3390/antiox13050574 · Cited by 42 · see citing works

Global analysis of S-nitrosylation sites in the wild type (APP) transgenic mouse brain: Clues for synaptic pathology

Zaręba-Kozioł, M., Szwajda, A., Dadlez, M., Wysłouch-Cieszyńska, A., & Lalowski, M. (2014) · Molecular &amp; Cellular Proteomics · doi:10.1074/mcp.m113.036079 · Cited by 39 · see citing works

Quantitative Phosphoproteomic Analyses of the Inferior Parietal Lobule from Three Different Pathological Stages of Alzheimer’s Disease

Triplett, J. C., Swomley, A. M., Cai, J., Klein, J. B., & Butterfield, D. A. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150417 · Cited by 39 · see citing works

Neuroprotective efficacy of thymoquinone against amyloid beta-induced neurotoxicity in human induced pluripotent stem cell-derived cholinergic neurons

Alhibshi, A., Odawara, A., & Suzuki, I. (2019) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2018.12.005 · Cited by 38 · see citing works

Redox Post-translational Modifications of Protein Thiols in Brain Aging and Neurodegenerative Conditions—Focus on S-Nitrosation

Finelli, M. J. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00254 · Cited by 37 · see citing works

Biliverdin Reductase-A integrates insulin signaling with mitochondrial metabolism through phosphorylation of GSK3β

Lanzillotta, C., Tramutola, A., Lanzillotta, S., Greco, V., Pagnotta, S. E., Sanchini, C., Angelantonio, S. D., Forte, E., Rinaldo, S., Paone, A., et al. (2024) · Redox Biology · doi:10.1016/j.redox.2024.103221 · Cited by 29 · see citing works

Potential Roles of Glucagon-Like Peptide-1 and Its Analogues in Dementia Targeting Impaired Insulin Secretion and Neurodegeneration

Mehan, S., Bhalla, S., Siddiqui, E. M., Sharma, N., Shandilya, A., & Khan, A. (2022) · Degenerative Neurological and Neuromuscular Disease · doi:10.2147/dnnd.s247153 · Cited by 29 · see citing works

Oxidative Stress in Brain in Amnestic Mild Cognitive Impairment

Butterfield, D. A. (2023) · Antioxidants · doi:10.3390/antiox12020462 · Cited by 28 · see citing works

Mitochondria as a target for neuroprotection: implications for Alzheimer´s disease

Cardoso, S., Seiça, R. M. F., & Moreira, P. I. (2016) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2016.1205488 · Cited by 27 · see citing works

Dynapenic abdominal obesity is associated with mild cognitive impairment in patients with cardiometabolic disease: a cross-sectional study

Oba, K., Tamura, Y., Ishikawa, J., Suzuki, H., Fujiwara, Y., Tachibana, A., Kodera, R., Toyoshima, K., Chiba, Y., & Araki, A. (2022) · BMC Geriatrics · doi:10.1186/s12877-022-02948-1 · Cited by 26 · see citing works

Redox Proteomic Profiling of Specifically Carbonylated Proteins in the Serum of Triple Transgenic Alzheimer’s Disease Mice

Shen, L., Chen, Y., Yang, A., Chen, C., Liao, L., Li, S., Ying, M., Tian, J., Liu, Q., & Ni, J. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17040469 · Cited by 26 · see citing works

Risk Classification in Mild Cognitive Impairment Patients for Developing Alzheimer's Disease

Zhou, B., Initiative, T. A. D. N., Nakatani, E., Teramukai, S., Nagai, Y., & Fukushima, M. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-112117 · Cited by 22 · see citing works

Redox imbalance and metabolic defects in the context of Alzheimer disease

Domenico, F. D., Lanzillotta, C., & Marzia Perluigi, A. (2024) · FEBS Letters · doi:10.1002/1873-3468.14840 · Cited by 22 · see citing works

Redox modifications in synaptic components as biomarkers of cognitive status, in brain aging and disease

Muñoz, P., Ardiles, Á. O., Pérez-Espinosa, B., Núñez-Espinosa, C. A., Paula-Lima, A. C., González-Billault, C. E., & Espinosa‐Parrilla, Y. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111250 · Cited by 19 · see citing works

Road to Alzheimer’s Disease: The Pathomechanism Underlying

Anand, R., Kaushal, A., Wani, W. Y., & Gill, K. D. (2011) · Pathobiology · doi:10.1159/000332218 · Cited by 15 · see citing works

The Potential of ‘Omics to Link Lipid Metabolism and Genetic and Comorbidity Risk Factors of Alzheimer’s Disease in African Americans

Stepler, K. E., & Robinson, R. A. S. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-05542-4_1 · Cited by 15 · see citing works

Phosphatidylethanolamine-Binding Protein 1 Ameliorates Ischemia-Induced Inflammation and Neuronal Damage in the Rabbit Spinal Cord

Kim, W., Cho, S. B., Jung, H. Y., Yoo, D. Y., Oh, J. K., Choi, G.-M., Cho, T. G., Kim, D. W., Hwang, I. K., Choi, S. Y., et al. (2019) · Cells · doi:10.3390/cells8111370 · Cited by 14 · see citing works

4-Hydroxyhexenal (HHE) Impairs Glutamate Transport in Astrocyte Cultures

Lovell, M. A., Bradley‐Whitman, M. A., & Fister, S. X. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-120409 · Cited by 13 · see citing works

Virus-Like Cytosolic and Cell-Free Oxidatively Damaged Nucleic Acids Likely Drive Inflammation, Synapse Degeneration, and Neuron Death in Alzheimer’s Disease

Sanders, O. D. (2022) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-220047 · Cited by 12 · see citing works

A Cu-bis(imidazole) Substrate Intermediate Is the Catalytically Competent Center for Catechol Oxidase Activity of Copper Amyloid-β

Bacchella, C., Dell’Acqua, S., Nicolis, S., Monzani, E., & Casella, L. (2021) · Inorganic Chemistry · doi:10.1021/acs.inorgchem.0c02243 · Cited by 12 · see citing works

Age-associated oxidative modifications of mitochondrial α-subunit of F1 ATP synthase from mouse skeletal muscles

Das, N. K., & Jana, C. K. (2015) · Free Radical Research · doi:10.3109/10715762.2015.1017477 · Cited by 11 · see citing works

Dynamic changes in the brain protein interaction network correlates with progression of Aβ42 pathology in Drosophila

Scholes, H. M., Cryar, A., Kerr, F., Sutherland, D., Gethings, L. A., Vissers, J. P. C., Lees, J., Orengo, C. A., Partridge, L., & Thalassinos, K. (2020) · Scientific Reports · doi:10.1038/s41598-020-74748-9 · Cited by 10 · see citing works

Comparative proteomic analyses of the parietal lobe from rhesus monkeys fed a high-fat/sugar diet with and without resveratrol supplementation, relative to a healthy diet: Insights into the roles of unhealthy diets and resveratrol on function

Swomley, A. M., Triplett, J. C., Keeney, J. T. R., Warrier, G., Pearson, K. J., Mattison, J. A., de Cabo, R., Cai, J., Klein, J. B., & Butterfield, D. A. (2016) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2016.10.006 · Cited by 9 · see citing works

Epigenomics of Alzheimer’s Disease

Bennett, D. A., Yu, L., Yang, J., Klein, H., & Jager, P. L. D. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-800802-7.00009-5 · Cited by 9 · see citing works

Neuropathological links between T2DM and LOAD: systematic review and meta-analysis

Lemche, E., Hortobágyi, T., Kiecker, C. M., & Turkheimer, F. (2025) · Physiological Reviews · doi:10.1152/physrev.00040.2024 · Cited by 8 · see citing works

Oxidative Stress in CD90+ T-cells of AβPP/PS-1 Transgenic Mice

Robinson, R. A. S., Cao, Z., & Williams, C. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-130665 · Cited by 6 · see citing works

3D-QSAR studies on lipid peroxidation inhibitory activity of chromone derivatives

Phosrithong, N., & Ungwitayatorn, J. (2016) · Medicinal Chemistry Research · doi:10.1007/s00044-016-1690-z · Cited by 6 · see citing works

Antioxidant Plant Polyphenols and Cognitive Disorders

Nowak, D. (2014) · Oxidative stress in applied basic research and clinical practice · doi:10.1007/978-1-4939-0440-2_26 · Cited by 5 · see citing works

Protein Carbonylation in Brains of Subjects with Selected Neurodegenerative Disorders

Reed, T. T., & Butterfield, D. A. (2017) · Wiley eBooks · doi:10.1002/9781119374947.ch8 · Cited by 3 · see citing works

GDF-11, GDF-15, Jag-1, and leptin in neuronal-derived extracellular vesicles as aging-related biomarkers to identify individuals at risk of Alzheimer's dementia: A pilot study

Lanzillotta, S., Boccardi, V., Zulli, B., Napoli, A., Paolozzi, G., Angelini, R., Ruzicka, B., Fratini, F., Guazzarini, A. G., Scamosci, M., et al. (2026) · Neurobiology of Disease · doi:10.1016/j.nbd.2026.107291 · Cited by 2 · see citing works

Lipid Peroxidation and Age-Related Neurodegenerative Disorders

Spickett, C., & Forman, H. (2015) · CRC Press eBooks · doi:10.1201/b18138-21 · Cited by 2 · see citing works

Targeting Mitochondria and Redox Dyshomeostasis in Brain Ageing: An Update

Cardoso, S., & Moreira, P. I. (2021) · Healthy ageing and longevity · doi:10.1007/978-3-030-84965-8_8 · Cited by 2 · see citing works

DOXORUBICIN-INDUCED, TNF-α-MEDIATED BRAIN OXIDATIVE STRESS, NEUROCHEMICAL ALTERATIONS, AND COGNITIVE DECLINE: INSIGHTS INTO MECHANISMS OF CHEMOTHERAPY INDUCED COGNITIVE IMPAIRMENT AND ITS PREVENTION

Keeney, J. T. R. (2013) · UKnowledge (University of Kentucky) · Cited by 2 · see citing works

Neuroinflammation and oxidative stress in the aging brain: Linking in metabolism, stem cells, proteostasis, and stress adaptation

d’Avila, J. C. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-817780-8.00004-9 · Cited by 2 · see citing works

Anti-apoptotic effect of memantine in a rat hippocampal cell model of Alzheimer's disease: morphology and cellular mechanismPreprint

Hashemi, M., Azizi, M. R., & Hashemi, F. (2022) · Research Square · doi:10.21203/rs.3.rs-1693554/v1 · Cited by 2 · see citing works

Implication du canal potassium Kv3.1 dans la lipotoxicité du 7-cétocholestérol, 24S-hydroxycholestérol et de l’acide tétracosanoïque sur des cellules nerveuses 158N et BV-2 : Etude des relations entre Kv3.1, homéostasie potassique et métabolisme peroxysomal dans la maladie d’Alzheimer

Bezine, M. (2017) · theses.fr (ABES) · doi:10.70675/a634c389z7b07z4830zb56dzbf7b53a56944 · Cited by 1 · see citing works

Molecular changes during the development of Alzheimer's disease

Wirz, K. T. S. (2013) · Data Archiving and Networked Services (DANS)

The Link Between Diabetes, Glucose Control, and Alzheimer's Disease and Neurodegenerative Diseases

Verdile, G., Fraser, P. E., & Martins, R. N. (2019) · Wiley eBooks · doi:10.1002/9781119356752.ch4

Mentoring in Life and Science

Robinson, R. A. S. (2021) · ACS symposium series · doi:10.1021/bk-2021-1381.ch010

Comparaison des effets de la viniférine et du resvératrol dans des modèles expérimentaux de la maladie d'Alzheimer

Freyssin, A. (2020) · theses.fr (ABES) · doi:10.70675/0db2e37dz547bz4731z852dz9b843c062cba

Redox proteomic analysis of carbonylated brain proteins in mild cognitive impairment and early Alzheimer’s disease

Sultana, R., Perluigi, M., Newman, S. F., Pierce, W. M., Cini, C., Coccia, R., & Butterfield, D. A. (2010) · Antioxidants &amp; Redox Signaling · doi:10.1089/ars.2009.2810 · Cited by 125 · see citing works

Redox Proteomics Identification of Oxidatively Modified Brain Proteins in Alzheimer's Disease and Mild Cognitive Impairment: Insights into the Progression of this Dementing Disorder

Butterfield, D. A., & Rukhsana Sultana, A. (2007) · Journal of Alzheimer s Disease · doi:10.3233/jad-2007-12107 · Cited by 126 · see citing works

Redox proteomic identification of 4-Hydroxy-2-nonenal-modified brain proteins in amnestic mild cognitive impairment: Insight into the role of lipid peroxidation in the progression and pathogenesis of Alzheimer's disease

Reed, T., Perluigi, M., Sultana, R., Pierce, W. M., Klein, J. B., Turner, D. M., Coccia, R., Markesbery, W. R., & Butterfield, D. A. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2007.12.007 · Cited by 257 · see citing works

Redox proteomics identification of oxidatively modified hippocampal proteins in mild cognitive impairment: Insights into the development of Alzheimer's disease

Butterfield, D. A., Poon, H. F., St. Clair, D., Keller, J. N., Pierce, W. M., Klein, J. B., & Markesbery, W. R. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.11.002 · Cited by 377 · see citing works

Comparison of peripheral oxidative markers between Mild Cognitive \nImpairement (MCI) and Alzheimer’s patients

Perrotte, M., Page, A. Y. L., Camponova, P., Fülöp, T., Rassart, É., & Ramassamy, C. (n.d.) · EspaceINRS (National Institute for Scientific Research (Canada))